Literature DB >> 19408608

Acute phase proteins in psoriasis.

Darko Biljan1, Mirna Situm, Kresimir Kostović, Tanja Batinac, Danica Matisić.   

Abstract

Psoriasis is a chronic, relapsing, inflammatory and hyperproliferative skin disorder. The levels of acute phase proteins are suggested to be elevated in those patients with acute disease. The expression of selected acute phase proteins as the parameters of humoral immunity has been analyzed in 70 patients with acute psoriasis and 40 healthy controls. The aim was to evaluate the inflammatory response in the exacerbation of psoriasis and to determine the correlation of these objective inflammatory parameters with clinical features of disease activity. Main demographic and epidemiologic features were, as well, analysed. The plasma levels of C-reactive protein (CRP) (chi2 = 23.61; p < 0.005), and alpha1-acid glycoprotein (alpha1-AGP) (chi2 = 7.42; p < 0.01) were significantly increased in those patients with acute phase of the disease compared to healthy controls. Our results suggest that psoriasis is an inflammatory disease and therefore its worsening seemed to be linked to the increase in the inflammatory response. It seems that CRP and al-AGP levels could serve as important prognostic factors for the worsening of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19408608

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  7 in total

1.  Lack of association between the genetic variations in the C-reactive protein gene and the risk of psoriasis among the Taiwanese.

Authors:  Ya-Ching Chang; Wei-Ming Wu; Lung-An Hsu
Journal:  Mol Biol Rep       Date:  2011-07-20       Impact factor: 2.316

2.  C-reactive protein serum level in patients with psoriasis before and after treatment with narrow-band ultraviolet B.

Authors:  Mahmoud Farshchian; Akram Ansar; Mohammadreza Sobhan; Valiollah Hoseinpoor
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

3.  Urinary Orosomucoid A Potential Marker Of Inflammation In Psoriasis.

Authors:  Péter Kustán; Tamás Kőszegi; Attila Miseta; Iván Péter; Zénó Ajtay; István Kiss; Balázs Németh
Journal:  Int J Med Sci       Date:  2018-07-13       Impact factor: 3.738

4.  Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients?

Authors:  Balázs Németh; Iván Péter; Imre Boncz; Anna Jagicza; István Kiss; Ágnes Csergő; Tamás Kőszegi; Péter Kustán; Iván G Horváth; Zénó Ajtay
Journal:  Ther Clin Risk Manag       Date:  2019-07-05       Impact factor: 2.423

5.  The Effects of Systemic Psoriasis Therapies on the C-Reactive Protein and the Neutrophil-Lymphocyte Ratio.

Authors:  Ezgi Aktaş Karabay; Aslı Aksu Çerman; Damla Demir; Ilknur Kıvanç Altunay
Journal:  Ann Dermatol       Date:  2019-10-31       Impact factor: 1.444

6.  Vaccinia virus-specific molecular signature in atopic dermatitis skin.

Authors:  Dmitry N Grigoryev; Michael D Howell; Tonya N Watkins; Yu-Chi Chen; Chris Cheadle; Mark Boguniewicz; Kathleen C Barnes; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2010-01       Impact factor: 10.793

7.  Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut.

Authors:  David Groeger; Liam O'Mahony; Eileen F Murphy; John F Bourke; Timothy G Dinan; Barry Kiely; Fergus Shanahan; Eamonn M M Quigley
Journal:  Gut Microbes       Date:  2013-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.